A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327

Inclusion Criteria: All Participants: · Body mass index of 18.0 to 34.0 kg/m\^2, inclusive, and body weight ≥ 50 kg Healthy Participants: * Male and female healthy volunteers ages 18 or age or older * No clinically significant deviation from normal in medical history, physical examination, electrocardiograms (ECGs) and clinical laboratory determinations Idiopathic Pulmonary Fibrosis (IPF) Participants: * Male and female participants aged 40 to 90 years * Diagnosis of IPF less than 6 years before randomization * Have no features supporting an alternative diagnosis on transbronchial biopsy, bronchoalveolar lavage or surgical lung biopsy Exclusion Criteria (all participants): * Severe motor problems that prevent the ability to lie still for PET imaging procedure * Significant acute or chronic medical illness in the opinion of the investigator in consultation with the BMS Medical Monitor, could jeopardize the subject's safety, tolerability, or pharmacokinetics of 18F-BMS-986327 * Current or recent (within 3 months of study drug administration) gastrointestinal disease that could impact upon the absorption of study drug * Any major surgery within 4 weeks of study drug administration Other protocol-defined criteria apply